Global drug giants double down on China amid trend to build self-reliant supply chains
Story summaryMultinationals are building self-reliant supply chains in China to insulate local markets from potential trade disruptions, say analysts
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.